InhalPlus

InhalPlus develops a novel, non-invasive inhalation technology for the targeted delivery of medication in preterm infants with respiratory diseases. Its patented bypass system enhances drug delivery efficiency by up to 3.2 times compared to current clinical inhalation therapies. The technology is designed to enable early intervention, prevent lung damage, and significantly reduce hospital stays and mortality in this highly vulnerable patient population.